Catalog Advanced Search

Search by Category
Search by Format
Search by Type
Sort By
Search by Keyword
Search by Category
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Favorites
Search by Keyword
Sort By

137 Results

  • Product Image: Cancer-Induced Bone Loss

    Cancer-Induced Bone Loss
    Contains 1 Component(s) Includes a Live Web Event on 02/04/2027 at 1:45 PM (EST)

    Join Dr. Hanna Taipaleenmäki as she discusses, "Cancer-Induced Bone Loss."

    Join Dr. Hanna Taipaleenmäki as she discusses, "Cancer-Induced Bone Loss."

    Learning objectives coming soon.

  • Product Image: ASBMR Primer-Based Webinar Series on Section VIII, “Metabolic Bone Issues in Orthopedics”

    ASBMR Primer-Based Webinar Series on Section VIII, “Metabolic Bone Issues in Orthopedics”
    Contains 1 Component(s) Includes a Live Web Event on 12/10/2026 at 11:00 AM (EST)

    Join us as Dr. Susan Bukata presents on Section VIII, “Metabolic Bone Issues in Orthopedics.”

    Supported by a donation from Amgen.

    Join us for a webinar series highlighting chapters from the 10th Edition of the Primer. As part of this initiative, a derivative eBook has been developed focusing specifically on metabolic bone issues in orthopedics. The webinar series serves as a companion educational offering, further highlighting key content from the eBook.

    In this webinar, Dr. Susan Bukata presents on Section VIII, “Metabolic Bone Issues in Orthopedics.”

    Susan V. Bukata, MD, FAOA, FAAOS

    Susan V. Bukata, MD, FAOA, FAAOS

    Professor and Chair

    University of California San Diego (UCSD) Orthopedics

    Susan V. Bukata, MD, FAOA, FAAOS, is a board-certified orthopedic surgeon who specializes in treating diseases and injuries that affect bones, joints, ligaments, and tendons. She is internationally recognized for her work on bone fragility disorders, which range from osteoporosis to rare genetic bone disease. Her National Institutes of Health-funded research focuses on fracture healing and developing ways to help patients heal faster, without additional surgical intervention.

    Prior to joining UC San Diego Health, Dr. Bukata served as orthopedic surgeon, professor and vice chair of orthopedics clinical operations, physician informaticist lead for musculoskeletal health providers and chief orthopedics liaison to community practice partners at UCLA Health.

    She holds a patent on technology for protecting and repairing cartilage and musculoskeletal soft tissue. She has published numerous research papers in peer-reviewed scientific journals, including Journal of Orthopaedic Research, Cancer, Spine, Science Translational Medicine and Tissue Engineering.

    Dr. Bukata currently serves on the Orthopaedic Research Society Executive Board of Directors, American Board of Orthopaedic Surgery Written Examination Field Task Force, and Musculoskeletal Tumor Society Education Committee. She has been named a "Top Doctor" numerous times by Castle Connolly America, Los Angeles Magazine and Hollywood Reporter, and has been recognized with several Patients' Choice Awards.

    She completed a fellowship in orthopedic oncology and metabolic bone disease at Memorial Sloan Kettering Cancer Center and Hospital for Special Surgery. She completed a residency and research fellowship in orthopedics at the University of Rochester. Dr. Bukata earned her medical degree at Columbia University.

  • Product Image: Primer-Based Webinar Series: "Epidemiology of Fractures and Causes Underlying Primary and Secondary Osteoporosis"

    Primer-Based Webinar Series: "Epidemiology of Fractures and Causes Underlying Primary and Secondary Osteoporosis"
    Contains 1 Component(s) Includes a Live Web Event on 12/01/2026 at 1:00 PM (EST)

    Join Dr. Peter Ebeling as he discusses, "Epidemiology of Fractures and Causes Underlying Primary and Secondary Osteoporosis."

    Supported by a donation from Amgen.

    Join us for a webinar series highlighting chapters from the 10th Edition of the Primer. As part of this initiative, a derivative eBook has been developed focusing specifically on metabolic bone issues in orthopedics. The webinar series serves as a companion educational offering, further highlighting key content from the eBook.

    In this webinar, Dr. Peter Ebeling presents, "Epidemiology of Fractures and Causes Underlying Primary and Secondary Osteoporosis."

    The learning objectives are to understand the:
    1. Effects of age, sex and geographic region on rates of fragility fractures.
    2. Importance of sex hormones for maintenance of bone health in women and men.
    3. Effects of glucocorticoids and other medications used to treat non-skeletal disorders on bone.
    4. Differing effects of obesity, bariatric surgery and diabetes on bone density and fractures.
    5. Other patient populations at risk of secondary osteoporosis.

  • Product Image: MRONJ Risk in Individuals on Pharmacotherapy for Fracture Prevention

    MRONJ Risk in Individuals on Pharmacotherapy for Fracture Prevention
    Contains 1 Component(s) Includes a Live Web Event on 11/23/2026 at 1:30 PM (EST)

    Join Drs. Laura Carbone and Pritee Shrestha as they discuss MRONJ risk in individuals on pharmacotherapy for fracture prevention.

    Join Drs. Laura Carbone and Pritee Shrestha as the present, "MRONJ Risk in Individuals on Pharmacotherapy for Fracture Prevention."

    Learning Objectives:
    1. Define medication-related osteonecrosis of the jaw (MRONJ) and discuss the challenges of identifying MRONJ using administrative claims data alone 
    2. Describe the utility of an algorithm developed using  Natural Language Processing (NLP) Methodology to ascertain MRONJ 
    3. Review the incidence of MRONJ among patients receiving bisphosphonates for fracture prevention, including relationships with duration of treatment with bisphosphonates. 
    4. Identify patient- and treatment-related risk factors for MRONJ in patients receiving bisphosphonate therapy. 

  • Product Image: Investigating Osteoporosis and Skeletal Fragility: From Diagnosis to Treatment Monitoring

    Investigating Osteoporosis and Skeletal Fragility: From Diagnosis to Treatment Monitoring
    Contains 1 Component(s) Includes a Live Web Event on 11/16/2026 at 10:00 AM (EST)

    Supported by a donation from Amgen. Join us for a webinar series highlighting chapters from the 10th Edition of the Primer. As part of this initiative, a derivative eBook has been developed focusing specifically on metabolic bone issues in orthopedics. The webinar series serves as a companion educational offering, further highlighting key content from the eBook. This webinar focuses on section IV, “Investigation of Metabolic Bone Diseases.” In this webinar, Drs. Richard Eastell, Marian Schini, and Tatiane Vilaca present, "Investigating Osteoporosis and Skeletal Fragility: From Diagnosis to Treatment Monitoring."

    Supported by a donation from Amgen.

    Join us for a webinar series highlighting chapters from the 10th Edition of the Primer. As part of this initiative, a derivative eBook has been developed focusing specifically on metabolic bone issues in orthopedics. The webinar series serves as a companion educational offering, further highlighting key content from the eBook. This webinar focuses on section IV, “Investigation of Metabolic Bone Diseases.”

    In this webinar, Drs. Richard Eastell, Marian Schini, and Tatiane Vilaca present, "Investigating Osteoporosis and Skeletal Fragility: From Diagnosis to Treatment Monitoring."

    Learning Objectives:
    1. Assess fracture risk following a fragility fracture, incorporating fracture recency, clinical risk factors, FRAX and bone mineral density (BMD). 

    2. Use and interpret dual-energy X-ray absorptiometry (DXA) appropriately in the assessment of osteoporosis, including recognition of important limitations and artefacts. 

    3. Recognize and diagnose vertebral fractures, using vertebral fracture assessment (VFA) and the algorithm-based qualitative (ABQ) approach to distinguish vertebral fracture from non-fracture deformity. 

    4. Investigate patients with skeletal fragility for underlying disorders, integrating clinical assessment, biochemical testing and appropriate use of specialist investigations. 

    5. Use bone mineral density and bone turnover markers to monitor osteoporosis treatment, including interpretation of changes in BMD, PINP and CTX and their roles in assessing treatment response and adherence. 

  • Product Image: Fracture Liaison Services: What’s the evidence? Can we innovate?

    Fracture Liaison Services: What’s the evidence? Can we innovate?
    Contains 1 Component(s) Includes a Live Web Event on 11/12/2026 at 12:00 PM (EST)

    Join Drs. Kenneth Saag and Maria (Maio) Danila as they discuss, "Fracture Liaison Services: What’s the evidence? Can we innovate?”

    Join Drs. Kenneth Saag and Maria (Maio) Danila as they discuss, "Fracture Liaison Services: What’s the evidence? Can we innovate?”

    Learning Objectives:
    1. Summarize the current evidence for Fracture Liaison Services (FLS) in improving treatment rates and reducing future fracture.
    2. Identify the main gaps and limitations for delivery of care through an FLS.
    3. Understand why real-world pragmatic trials are needed to address comparative effectiveness.
    4. Apprise emerging innovations that could expand FLS reach and effectiveness.

    Kenneth Saag, MD, MSc

    Kenneth Saag, MD, MSc

    Director of the Division of Clinical Immunology and Rheumatology and Professor

    University of Alabama at Birmingham (UAB)

    Dr. Saag is the Anna Lois Waters Endowed Chair and Director of the Division of Clinical Immunology and Rheumatology and the Comprehensive Arthritis, Musculoskeletal, Bone, and Autoimmunity Center at the University of Alabama at Birmingham (UAB). He received his undergraduate degree in Bioengineering from the University of Michigan and his MD from Northwestern University. He joined the faculty at Iowa as an Assistant Professor until moving to UAB in1998. Dr. Saag’s continuously funded research has advanced the fields of novel therapeutics and outcomes research in osteoporosis and gout. He has authored more than 430 peer-reviewed manuscripts, including 3 first-author New England Journal of Medicine articles. He has also authored more than 100 reviews, editorials, and book chapters, and the handbook Diagnosis and Management of Osteoporosis. He has served on the editorial boards of many medical journals and is currently Deputy Editor of Arthritis and Rheumatology. Dr. Saag was the 85th ACR President in 2021–2022. 

    Maria (Maio) I. Danila, MD, MSc, MSPH

    Maria (Maio) I. Danila, MD, MSc, MSPH

    Associate Division Director for Clinical Research and Professor

    University of Alabama at Birmingham (UAB)

    Dr. Danila is the UAB Endowed Professor in Musculoskeletal Outcomes Research in the Division of Clinical Immunology and Rheumatology, where she serves as Director of Patient Oriented Research. She also holds an appointment as a Physician Scientist in the Geriatric Research Education and Clinical Center at the Birmingham VA Medical Center. Dr. Danila received her MD degree from Carol Davila University of Medicine and Pharmacy. She is a rheumatologist and implementation science researcher focused on improving the quality of medical care. Her research program focuses on i) the design and evaluation of multi-modal interventions to improve outcomes for patients with osteoporosis, rheumatoid arthritis, and gout; ii) re-designing healthcare services and leveraging new technologies (e.g., telehealth, infrared thermography, artificial intelligence) in clinical practice to increase effectiveness of care delivery. Dr. Danila has been leading research projects funded by the National Institutes of Health, the Patient Centered Outcomes Institute, and the Rheumatology Research Foundation. She has served on Editorial Board for multiple rheumatology journals and currently serves as an Associate Editor for the journal Arthritis & Rheumatology. 

  • Product Image: Bone Marrow Adiposity and Osteoporosis

    Bone Marrow Adiposity and Osteoporosis
    Contains 1 Component(s) Includes a Live Web Event on 11/09/2026 at 11:30 AM (EST)

    Join Drs. Julien Paccou and Ziru Li as they present, "Bone Marrow Adiposity and Osteoporosis."

    Join Drs. Julien Paccou and Ziru Li as they present, "Bone Marrow Adiposity and Osteoporosis."

    Learning Objectives (Clinical, Dr. Julien Paccou):
    1. Describe the clinical relevance of bone marrow adiposity in the pathophysiology of osteoporosis.
    2. Identify patient populations in whom bone marrow adiposity expansion is most clinically significant (e.g., aging, menopause, diabetes, glucocorticoid use).
    3. Discuss how imaging of marrow adiposity may inform fracture risk assessment.
    4. Review the clinical implications of bone marrow adiposity for the management and treatment of osteoporosis.

    Learning Objectives (Basic, Dr. Ziru Li):
    1. Recognize the complexity and unique features of experimental models used to study bone marrow adiposity and bone metabolism.
    2. Discuss emerging molecular and cellular mechanisms linking bone marrow adipocytes to skeletal homeostasis.
    3. Evaluate current challenges and knowledge gaps in understanding the role of bone marrow adiposity in skeletal health and osteoporosis.
    4. Identify key unanswered questions and emerging research directions in bone marrow adiposity research.

    Julien Paccou, MD, PhD

    Julien Paccou, MD, PhD

    Professor and Deputy Director

    University of Lille

    Julien Paccou is Professor of Rheumatology at Lille University Hospital and Deputy Director of the MABLab (ULR 4490), Bone and Marrow Adiposity Relationships (University of Lille, France). He obtained his PhD from the University of Picardie Jules Verne in 2013. In 2014, he completed a postdoctoral fellowship at the MRC Lifecourse Epidemiology Unit, University of Southampton (UK). 

    His research focuses on osteoporosis, with particular emphasis on bone marrow adiposity, obesity, and weight loss interventions (including bariatric surgery and GLP-1 receptor agonists). His team combines clinical research, epidemiology, and advanced marrow adiposity imaging to improve the understanding and management of metabolic bone diseases. 

    Julien Paccou is Secretary of the Bone Marrow Adiposity Society (BMAS) and Co-Chair of the European Calcified Tissue Society (ECTS) Clinical Action Group. He also serves on the Committee of Scientific Advisors and the Capture the Fracture Steering Committee of the International Osteoporosis Foundation (IOF), the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). In 2025, he received the BMAS Clinical Scientist Award. 

    Ziru Li, PhD

    Ziru Li, PhD

    Faculty Scientist II and Assistant Professor

    MaineHealth Institute for Research and Tufts University School of Medicine

    Dr. Ziru Li is a Faculty Scientist II at the MaineHealth Institute for Research, Assistant Professor at Tufts University School of Medicine, and Graduate Faculty member at the University of Maine Graduate School of Biomedical Science and Engineering. Her research focuses on the biology and functions of bone marrow adipocytes, including their roles in local skeletal and hematopoietic homeostasis and their systemic effects on the heart. In addition, her research explores the gut–bone axis, with a particular emphasis on elucidating the mechanisms underlying bariatric surgery-induced bone loss. Her laboratory integrates genetic mouse models, cellular and molecular approaches, and multi-omics technologies to define how bone marrow adiposity influences bone metabolism and systemic physiology. Dr. Li has published extensively in the fields of bone marrow adipose tissue, adipocyte biology, metabolism, and endocrine regulation. She serves on the editorial board of the Journal of Biological Chemistry, holds active memberships in ASBMR and the Endocrine Society, and is a Scientific Board Member of the Bone Marrow Adiposity Society. 

  • Product Image: Highlights of Osteoporosis Treatment from the Primer 10th Edition

    Highlights of Osteoporosis Treatment from the Primer 10th Edition
    Contains 1 Component(s)

    Join Dr. E. Michael Lewiecki as he presents, "Highlights of Osteoporosis Treatment from the Primer 10th Edition." Supported by a donation from Amgen.

    Supported by a donation from Amgen.

    Join us for a webinar series highlighting chapters from the 10th Edition of the Primer. As part of this initiative, a derivative eBook has been developed focusing specifically on metabolic bone issues in orthopedics. The webinar series serves as a companion educational offering, further highlighting key content from the eBook.

    In this webinar, Dr. E. Michael Lewiecki presents, “Highlights of Osteoporosis Treatment from the Primer, 10th Edition.”

    Learning Objectives:
    1. Understand management strategies for osteoporosis. 
    2. Review challenges in the care of osteoporosis in older patients. 
    3. Discuss current concepts in hormonal treatments for skeletal care in women.

    Dr. E. Michael Lewiecki

    Dr. E. Michael Lewiecki

    Director

    New Mexico Clinical Research & Osteoporosis Center and Bone Health ECHO, UNM Health Sciences Center

    E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of the New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health ECHO at the University of New Mexico Health Sciences Center, where he specializes in osteoporosis and metabolic bone diseases. He is an experienced clinician, educator, and researcher who has led numerous osteoporosis clinical trials and authored more than 380 peer-reviewed publications with over 44,000 citations. Dr. Lewiecki is a past president of the International Society for Clinical Densitometry and current president of the Osteoporosis Foundation of New Mexico, reflecting his longstanding leadership in bone health. He also serves on the editorial boards of leading osteoporosis journals, directs the annual Santa Fe Bone Symposium, and has received prestigious national and international awards for his contributions to the field. 

  • ASBMR 2026 Annual Meeting Recordings
    Contains 61 Component(s) Recorded On: 10/08/2026

    Edited Recordings from the ASBMR 2026 Annual Meeting, October 9-12, 2026, Boston, MA.

    ASBMR 2026 Annual Meeting Session Recordings (October 9-12, 2026)
    John B. Hynes Veterans Memorial Convention Center, Boston, Massachusetts.

    To access the recordings from the ASBMR 2026 Annual Meeting, please click the Contents tab. If you registered for the ASBMR Annual Meeting, you DO NOT need to purchase recordings - you should have received an email with instructions to access the recordings. Please contact [email protected] with any questions! 

  • Product Image: Public Outreach Session: An Owner’s Manual for the Skeleton: Protecting Your Bones Through Movement, Medicine, and Menopause

    Public Outreach Session: An Owner’s Manual for the Skeleton: Protecting Your Bones Through Movement, Medicine, and Menopause
    Contains 1 Component(s)

    Join leading bone health experts for an engaging, easy-to-understand conversation about keeping your bones strong throughout life. You'll hear practical advice you can put into action, learn when to talk with your healthcare provider about bone health, and leave feeling more informed about how to support your long-term health. Presentations: Talking to Your Physician About Bone Health (Eric S. Orwoll) Exercise and Bone Health (Lora M. Giangregorio, PhD) Menopause (Joy Tsai, MD)

    Join leading bone health experts for an engaging, easy-to-understand conversation about keeping your bones strong throughout life. You'll hear practical advice you can put into action, learn when to talk with your healthcare provider about bone health, and leave feeling more informed about how to support your long-term health. 

    Presentations: Talking to Your Physician About Bone Health (Eric S. Orwoll) Exercise and Bone Health (Lora M. Giangregorio, PhD) Menopause (Joy Tsai, MD)